## **Core Concept**
The question pertains to the genetic mutations associated with malignant melanoma, a type of skin cancer known for its aggressive nature and poor prognosis if not detected early. Malignant melanoma arises from melanocytes, the cells responsible for producing melanin. Genetic mutations play a crucial role in the development and progression of this cancer.

## **Why the Correct Answer is Right**
The correct answer, **BRAF**, is a gene that encodes for a protein called B-Raf, which is involved in sending signals inside cells and directing cell growth. In malignant melanoma, a specific mutation in the BRAF gene, known as the V600E mutation, is commonly found. This mutation leads to the production of an abnormal B-Raf protein that is always active and doesn't require the usual signal to start the cell division process, leading to uncontrolled cell growth and cancer. The BRAF V600E mutation is present in approximately 50% of melanoma cases and is a target for specific therapies.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain genetic alterations can be found in various types of cancer, this option is not specified and does not directly relate to the well-known mutations in malignant melanoma.
- **Option B:** This option might refer to other genetic mutations or alterations but is not directly linked to the most commonly recognized mutation in malignant melanoma.
- **Option D:** Similarly, this option does not specify a known mutation directly associated with malignant melanoma.

## **Clinical Pearl / High-Yield Fact**
A significant clinical pearl is that the presence of the BRAF V600E mutation in malignant melanoma patients can be targeted with specific inhibitors, such as vemurafenib and dabrafenib, which have shown significant efficacy in improving outcomes for these patients. This highlights the importance of genetic testing in melanoma to guide treatment decisions.

## **Correct Answer:** . BRAF.